A First-in-Human Study of PRL3-ZUMAB

Clinical trial NCT03191682 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT03191682
Sponsor: National University Hospital, Singapore
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Advanced Solid Tumors

Start date: 2017-02-20
Primary completion: 2027-02-20
Enrollment: 38

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.